TEF-1 and C/EBPβ are major p38α MAR-regulated transcription factors in proliferating cardiomyocytes

被引:35
作者
Ambrosino, Concetta
Iwata, Tomoko
Scafoglio, Claudio
Mallardo, Massimo
Klein, Ruediger
Nebreda, Angel R. [1 ]
机构
[1] European Mol Biol Lab, D-69117 Heidelberg, Germany
[2] Univ Naples 2, Dipartimento Patol Gen, I-80138 Naples, Italy
[3] Max Planck Inst Neurobiol, Dept Mol Neurobiol, D-82152 Martinsried, Germany
[4] Univ Naples Federico II, Dipartimento Biochim & Biotecnol Med, Naples, Italy
[5] CNIO, Spanish Natl Canc Ctr, E-28029 Madrid, Spain
关键词
cardiomyocyte; collagen; extracellular matrix (ECM); gene expression; p38; MAPK; transcription factor;
D O I
10.1042/BJ20051502
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
p38 MAPKs (mitogen-activated protein kinases) play important roles in the regulation of cellular responses to environmental stress. Recently, this signalling pathway has also been implicated in the regulation of processes unrelated to stress, for example, in T lymphocytes and cardiomyocytes. In order to identify molecular targets responsible for the housekeeping functions of p38 MAPKs, we have analysed the differences in the transcriptomes of normally proliferating wild-type and p38 alpha knockout immortalized embryonic cardiomyocytes. Interestingly, many potential components of the myocardium extracellular matrix were found to be upregulated in the absence of p38 alpha. Further analysis of the microarray data identified TEF-1 (transcriptional enhancer factor-1), a known regulator of heart-specific gene expression, and C/EBP beta (CCAAT/enhancer-binding protein beta), as the two transcription factors the binding sites of which were most enriched in the promoters of p38 alpha-regulated genes. We have focused on the study of the extracellular matrix component COL1A1 (alpha 1 chain of type I collagen) and found evidence for the involvement of both TEF-1 and C/EBP beta in the p38 alpha-dependent inhibition of COL1A1 transcription. Our data therefore show that p38 MAPKs regulate TEF-1 and C/EBP beta transcriptional activity in the absence of environmental stress and suggests a role for p38a in the expression of extracellular matrix components that maintain organ architecture.
引用
收藏
页码:163 / 172
页数:10
相关论文
共 50 条
[1]   Essential role of p38α MAP kinase in placental but not embryonic cardiovascular development [J].
Adams, RH ;
Porras, A ;
Alonso, G ;
Jones, M ;
Vintersten, K ;
Panelli, S ;
Valladares, A ;
Perez, L ;
Klein, R ;
Nebreda, AR .
MOLECULAR CELL, 2000, 6 (01) :109-116
[2]   Deficiency of the stress kinase p38α results in embryonic lethality:: Characterization of the kinase dependence of stress responses of enzyme-deficient embryonic stem cells [J].
Allen, M ;
Svensson, L ;
Roach, M ;
Hambor, J ;
McNeish, J ;
Gabel, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (05) :859-869
[3]   Differential activation of p38 mitogen-activated protein kinase isoforms depending on signal strength [J].
Alonso, G ;
Ambrosino, C ;
Jones, M ;
Nebreda, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (51) :40641-40648
[4]   Negative feedback regulation of MKK6 mRNA stability by p38α mitogen-activated protein kinase [J].
Ambrosino, C ;
Mace, G ;
Galban, S ;
Fritsch, C ;
Vintersten, K ;
Black, E ;
Gorospe, M ;
Nebreda, AR .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (01) :370-381
[5]   Identification of new sites of binding and activation of the murine α1(I) collagen promoter by CCAAT/enhancer binding protein β [J].
Attard, FA ;
Wang, L ;
Potter, JJ ;
Rennie-Tankersley, L ;
Mezey, E .
DNA AND CELL BIOLOGY, 2001, 20 (08) :455-463
[6]   Regulation of NF-kappa B through the nuclear processing of p105 (NF-kappa B1) in Epstein-Barr virus-immortalized B cell lines [J].
Baldassarre, F ;
Mallardo, M ;
Mezza, E ;
Scala, G ;
Quinto, I .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) :31244-31248
[7]   Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart - p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion [J].
Bogoyevitch, MA ;
GillespieBrown, J ;
Ketterman, AJ ;
Fuller, SJ ;
BenLevy, R ;
Ashworth, A ;
Marshall, CJ ;
Sugden, PH .
CIRCULATION RESEARCH, 1996, 79 (02) :162-173
[8]   Mechanism of p38 MAP kinase activation in vivo [J].
Brancho, D ;
Tanaka, N ;
Jaeschke, A ;
Ventura, JJ ;
Kelkar, N ;
Tanaka, Y ;
Kyuuma, M ;
Takeshita, T ;
Flavell, RA ;
Davis, RJ .
GENES & DEVELOPMENT, 2003, 17 (16) :1969-1978
[9]   Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NEAT signaling [J].
Braz, JC ;
Bueno, OF ;
Liang, QR ;
Wilkins, BJ ;
Dai, YS ;
Parsons, S ;
Braunwart, J ;
Glascock, BJ ;
Klevitsky, R ;
Kimball, TF ;
Hewett, TE ;
Molkentin, JD .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (10) :1475-1486
[10]   The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice [J].
Bueno, OF ;
De Windt, LJ ;
Tymitz, KM ;
Witt, SA ;
Kimball, TR ;
Klevitsky, R ;
Hewett, TE ;
Jones, SP ;
Lefer, DJ ;
Peng, CF ;
Kitsis, RN ;
Molkentin, JD .
EMBO JOURNAL, 2000, 19 (23) :6341-6350